ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery

View Author Information
† ‡ § Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, and §Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States
Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Melbourne, Australia
*Phone: 615-322-8700. Fax: 615-345-6532. E-mail: [email protected]
Cite this: J. Med. Chem. 2012, 55, 4, 1445–1464
Publication Date (Web):December 9, 2011
https://doi.org/10.1021/jm201139r
Copyright © 2011 American Chemical Society

    Article Views

    7293

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 192 publications.

    1. Jing-Jing Zhang, Hualong Fu, Ruofan Lin, Jingyin Zhou, Ahmed Haider, Weiwei Fang, Nehal H. Elghazawy, Jian Rong, Jiahui Chen, Yinlong Li, Chongzhao Ran, Thomas L. Collier, Zhen Chen, Steven H. Liang. Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography. Journal of Medicinal Chemistry 2023, 66 (16) , 10889-10916. https://doi.org/10.1021/acs.jmedchem.3c00573
    2. Corinna Schüß, Oanh Vu, Nigam M. Mishra, Iain R. Tough, Yu Du, Jan Stichel, Helen M. Cox, C. David Weaver, Jens Meiler, Kyle A. Emmitte, Annette G. Beck-Sickinger. Structure–Activity Relationship Study of the High-Affinity Neuropeptide Y4 Receptor Positive Allosteric Modulator VU0506013. Journal of Medicinal Chemistry 2023, 66 (13) , 8745-8766. https://doi.org/10.1021/acs.jmedchem.3c00383
    3. Oscar Díaz, Pedro Renault, Jesús Giraldo. Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation. ACS Omega 2022, 7 (42) , 37873-37884. https://doi.org/10.1021/acsomega.2c04980
    4. Javier García-Cárceles, Henar Vázquez-Villa, José Brea, David Ladron de Guevara-Miranda, Giovanni Cincilla, Melchor Sánchez-Martínez, Anabel Sánchez-Merino, Sergio Algar, María Teresa de los Frailes, Richard S. Roberts, Juan A. Ballesteros, Fernando Rodríguez de Fonseca, Bellinda Benhamú, María I. Loza, María L. López-Rodríguez. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease. Journal of Medicinal Chemistry 2022, 65 (18) , 12256-12272. https://doi.org/10.1021/acs.jmedchem.2c00949
    5. Swagat Sharma, Qi Peng, Anish K. Vadukoot, Christopher D. Aretz, Aaron A. Jensen, Alexander I. Wallick, Xinzhong Dong, Corey R. Hopkins. Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1. ACS Medicinal Chemistry Letters 2022, 13 (5) , 841-847. https://doi.org/10.1021/acsmedchemlett.2c00100
    6. Thuy Nguyen, Thomas F. Gamage, David B. Finlay, Ann M. Decker, Tiffany L. Langston, Daniel Barrus, Michelle Glass, Jun-Xu Li, Terry P. Kenakin, Yanan Zhang. Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior. Journal of Medicinal Chemistry 2022, 65 (1) , 257-270. https://doi.org/10.1021/acs.jmedchem.1c01432
    7. Lisa Barbaro, Alice L. Rodriguez, Ashlyn N. Blevins, Jonathan W. Dickerson, Natasha Billard, Olivier Boutaud, Jerri L. Rook, Colleen M. Niswender, P.Jeffrey Conn, Darren W. Engers, Craig W. Lindsley. Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype. ACS Bio & Med Chem Au 2021, 1 (1) , 21-30. https://doi.org/10.1021/acsbiomedchemau.1c00024
    8. Natalia J. Martinez, John C. Braisted, Patricia K. Dranchak, John J. Moran, Hunter Larson, Bryan Queme, Evgenia Pak, Amalia Dutra, Ganesha Rai, Ken Chih-Chien Cheng, John Svaren, James Inglese. Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery. ACS Pharmacology & Translational Science 2021, 4 (4) , 1422-1436. https://doi.org/10.1021/acsptsci.1c00110
    9. Maria Ricart-Ortega, Alice E. Berizzi, Vanessa Pereira, Fanny Malhaire, Juanlo Catena, Joan Font, Xavier Gómez-Santacana, Lourdes Muñoz, Charleine Zussy, Carmen Serra, Xavier Rovira, Cyril Goudet, Amadeu Llebaria. Mechanistic Insights into Light-Driven Allosteric Control of GPCR Biological Activity. ACS Pharmacology & Translational Science 2020, 3 (5) , 883-895. https://doi.org/10.1021/acsptsci.0c00054
    10. Bingsong Han, Francesco G. Salituro, Maria-Jesus Blanco. Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. ACS Medicinal Chemistry Letters 2020, 11 (10) , 1810-1819. https://doi.org/10.1021/acsmedchemlett.9b00655
    11. Junliang Hao, James P. Beck, John M. Schaus, Joseph H. Krushinski, Qi Chen, Christopher D. Beadle, Paloma Vidal, Matthew R. Reinhard, Bruce A. Dressman, Steven M. Massey, Serge L. Boulet, Michael P. Cohen, Brian M. Watson, David Tupper, Kevin M. Gardinier, Jason Myers, Anette M. Johansson, Jeffery Richardson, Daniel S. Richards, Erik J. Hembre, David M. Remick, David A. Coates, Rajni M. Bhardwaj, Benjamin A. Diseroad, David Bender, Greg Stephenson, Craig D. Wolfangel, Nuria Diaz, Brian G. Getman, Xu-shan Wang, Beverly A. Heinz, Jeff W. Cramer, Xin Zhou, Deanna L. Maren, Julie F. Falcone, Rebecca A. Wright, Stephen N. Mitchell, Guy Carter, Charles R. Yang, Robert F. Bruns, Kjell A. Svensson. Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor. Journal of Medicinal Chemistry 2019, 62 (19) , 8711-8732. https://doi.org/10.1021/acs.jmedchem.9b01234
    12. Aaron M. Bender, Aaron T. Garrison, Craig W. Lindsley. The Muscarinic Acetylcholine Receptor M5: Therapeutic Implications and Allosteric Modulation. ACS Chemical Neuroscience 2019, 10 (3) , 1025-1034. https://doi.org/10.1021/acschemneuro.8b00481
    13. Christopher T. Wild, Joanna M. Miszkiel, Eric A. Wold, Claudia A. Soto, Chunyong Ding, Rachel M. Hartley, Mark A. White, Noelle C. Anastasio, Kathryn A. Cunningham, Jia Zhou. Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor. Journal of Medicinal Chemistry 2019, 62 (1) , 288-305. https://doi.org/10.1021/acs.jmedchem.8b00401
    14. Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, Jia Zhou. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. Journal of Medicinal Chemistry 2019, 62 (1) , 88-127. https://doi.org/10.1021/acs.jmedchem.8b00875
    15. Jerri M. Rook, Jeanette L. Bertron, Hyekyung P. Cho, Pedro M. Garcia-Barrantes, Sean P. Moran, James T. Maksymetz, Kellie D. Nance, Jonathan W. Dickerson, Daniel H. Remke, Sichen Chang, Joel M. Harp, Anna L. Blobaum, Colleen M. Niswender, Carrie K. Jones, Shaun R. Stauffer, P. Jeffrey Conn, Craig W. Lindsley. A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity. ACS Chemical Neuroscience 2018, 9 (9) , 2274-2285. https://doi.org/10.1021/acschemneuro.8b00131
    16. Aaron M. Bender, Hyekyung P. Cho, Kellie D. Nance, Kaelyn S. Lingenfelter, Vincent B. Luscombe, Patrick R. Gentry, Karl Voigtritter, Alice E. Berizzi, Patrick M. Sexton, Christopher J. Langmead, Arthur Christopoulos, Charles W. Locuson, Thomas M. Bridges, Sichen Chang, Jordan C. O’Neill, Xiaoyan Zhan, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley. Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold. ACS Chemical Neuroscience 2018, 9 (7) , 1572-1581. https://doi.org/10.1021/acschemneuro.8b00126
    17. Alice E. Berizzi, Aaron M. Bender, Craig W. Lindsley, P. Jeffrey Conn, Patrick M. Sexton, Christopher J. Langmead, Arthur Christopoulos. Structure–Activity Relationships of Pan-Gαq/11 Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators. ACS Chemical Neuroscience 2018, 9 (7) , 1818-1828. https://doi.org/10.1021/acschemneuro.8b00136
    18. Tingting Fu, Guoxun Zheng, Gao Tu, Fengyuan Yang, Yuzong Chen, Xiaojun Yao, Xiaofeng Li, Weiwei Xue, Feng Zhu. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations. ACS Chemical Neuroscience 2018, 9 (6) , 1492-1502. https://doi.org/10.1021/acschemneuro.8b00059
    19. Xiaofei Zhang, Katsushi Kumata, Tomoteru Yamasaki, Ran Cheng, Akiko Hatori, Longle Ma, Yiding Zhang, Lin Xie, Lu Wang, Hye Jin Kang, Douglas J. Sheffler, Nicholas D. P. Cosford, Ming-Rong Zhang, and Steven H. Liang . Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2. ACS Chemical Neuroscience 2017, 8 (9) , 1937-1948. https://doi.org/10.1021/acschemneuro.7b00098
    20. Jie Wang, Lili Wang, Shan Guo, Shanke Zha, and Jin Zhu . Synthesis of 2,3-Benzodiazepines via Rh(III)-Catalyzed C–H Functionalization of N-Boc Hydrazones with Diazoketoesters. Organic Letters 2017, 19 (13) , 3640-3643. https://doi.org/10.1021/acs.orglett.7b01642
    21. Jerri M. Rook, Masahito Abe, Hyekyung P. Cho, Kellie D. Nance, Vincent B. Luscombe, Jeffrey J. Adams, Jonathan W. Dickerson, Daniel H. Remke, Pedro M. Garcia-Barrantes, Darren W. Engers, Julie L. Engers, Sichen Chang, Jarrett J. Foster, Anna L. Blobaum, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, and Craig W. Lindsley . Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs. ACS Chemical Neuroscience 2017, 8 (4) , 866-883. https://doi.org/10.1021/acschemneuro.6b00429
    22. Dong Guo, Laura H. Heitman, and Adriaan P. IJzerman . Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors. Chemical Reviews 2017, 117 (1) , 38-66. https://doi.org/10.1021/acs.chemrev.6b00025
    23. Graeme Milligan, Bharat Shimpukade, Trond Ulven, and Brian D. Hudson . Complex Pharmacology of Free Fatty Acid Receptors. Chemical Reviews 2017, 117 (1) , 67-110. https://doi.org/10.1021/acs.chemrev.6b00056
    24. Pedro M. Garcia-Barrantes, Hyekyung P. Cho, Colleen M. Niswender, Frank W. Byers, Charles W. Locuson, Anna L. Blobaum, Zixiu Xiang, Jerri M. Rook, P. Jeffrey Conn, and Craig W. Lindsley . Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics. Journal of Medicinal Chemistry 2015, 58 (20) , 7959-7971. https://doi.org/10.1021/acs.jmedchem.5b00727
    25. Tracey Huynh, Celine Valant, Ian T. Crosby, Patrick M. Sexton, Arthur Christopoulos, and Ben Capuano . Synthesis and Pharmacological Evaluation of M4 Muscarinic Receptor Positive Allosteric Modulators Derived from VU10004. ACS Chemical Neuroscience 2015, 6 (6) , 838-844. https://doi.org/10.1021/acschemneuro.5b00035
    26. Lindsey C. Morris, Kellie D. Nance, Patrick R. Gentry, Emily L. Days, C. David Weaver, Colleen M. Niswender, Analisa D. Thompson, Carrie K. Jones, Chuck W. Locuson, Ryan D. Morrison, J. Scott Daniels, Kevin D. Niswender, and Craig W. Lindsley . Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM). Journal of Medicinal Chemistry 2014, 57 (23) , 10192-10197. https://doi.org/10.1021/jm501375c
    27. Romeo Romagnoli, Pier Giovanni Baraldi, Adriaan P. IJzerman, Arnault Massink, Olga Cruz-Lopez, Luisa Carlota Lopez-Cara, Giulia Saponaro, Delia Preti, Mojgan Aghazadeh Tabrizi, Stefania Baraldi, Allan R. Moorman, Fabrizio Vincenzi, Pier Andrea Borea, and Katia Varani . Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4′-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene. Journal of Medicinal Chemistry 2014, 57 (18) , 7673-7686. https://doi.org/10.1021/jm5008853
    28. Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Meredith J. Noetzel, Hyekyung P. Cho, Atin Lamsal, Emery Smith, Peter Chase, Peter S. Hodder, Colleen M. Niswender, J. Scott Daniels, P. Jeffrey Conn, Craig W. Lindsley, and Michael R. Wood . Development of a Highly Potent, Novel M5 Positive Allosteric Modulator (PAM) Demonstrating CNS Exposure: 1-((1H-Indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380). Journal of Medicinal Chemistry 2014, 57 (18) , 7804-7810. https://doi.org/10.1021/jm500995y
    29. Nadezhda German, Ann M. Decker, Brian P. Gilmour, Elaine A. Gay, Jenny L. Wiley, Brian F. Thomas, and Yanan Zhang . Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). Journal of Medicinal Chemistry 2014, 57 (18) , 7758-7769. https://doi.org/10.1021/jm501042u
    30. Craig W. Lindsley . 2013 Philip S. Portoghese Medicinal Chemistry Lectureship: Drug Discovery Targeting Allosteric Sites. Journal of Medicinal Chemistry 2014, 57 (18) , 7485-7498. https://doi.org/10.1021/jm5011786
    31. Raveendra-Panickar Dhanya, Douglas J. Sheffler, Russell Dahl, Melinda Davis, Pooi San Lee, Li Yang, Hilary Highfield Nickols, Hyekyung P. Cho, Layton H. Smith, Manoranjan S. D’Souza, P. Jeffrey Conn, Andre Der-Avakian, Athina Markou, and Nicholas D. P. Cosford . Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence. Journal of Medicinal Chemistry 2014, 57 (10) , 4154-4172. https://doi.org/10.1021/jm5000563
    32. Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Nathan R. Kett, Joel M. Harp, Hyekyung P. Cho, Emery Smith, Peter Chase, Peter S. Hodder, Colleen M. Niswender, J. Scott Daniels, P. Jeffrey Conn, Michael R. Wood, and Craig W. Lindsley . Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375). Journal of Medicinal Chemistry 2013, 56 (22) , 9351-9355. https://doi.org/10.1021/jm4013246
    33. Mark Turlington, Meredith J. Noetzel, Aspen Chun, Ya Zhou, Rocco D. Gogliotti, Elizabeth D. Nguyen, Karen J. Gregory, Paige N. Vinson, Jerri M. Rook, Kiran K. Gogi, Zixiu Xiang, Thomas M. Bridges, J. Scott Daniels, Carrie Jones, Colleen M. Niswender, Jens Meiler, P. Jeffrey Conn, Craig W. Lindsley, and Shaun R. Stauffer . Exploration of Allosteric Agonism Structure–Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254). Journal of Medicinal Chemistry 2013, 56 (20) , 7976-7996. https://doi.org/10.1021/jm401028t
    34. Tracey Huynh, Celine Valant, Ian T. Crosby, Patrick M. Sexton, Arthur Christopoulos, and Ben Capuano . Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor. Journal of Medicinal Chemistry 2013, 56 (20) , 8196-8200. https://doi.org/10.1021/jm401032k
    35. Russell J. Amato, Andrew S. Felts, Alice L. Rodriguez, Daryl F. Venable, Ryan D. Morrison, Frank W. Byers, J. Scott Daniels, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Carrie K. Jones, and Kyle A. Emmitte . Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction. ACS Chemical Neuroscience 2013, 4 (8) , 1217-1228. https://doi.org/10.1021/cn400070k
    36. Cody J. Wenthur, Ryan Morrison, Andrew S. Felts, Katrina A. Smith, Julie L. Engers, Frank W. Byers, J. Scott Daniels, Kyle A. Emmitte, P. Jeffrey Conn, and Craig W. Lindsley . Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu3 Selective and CNS Penetrant Negative Allosteric Modulator (NAM). Journal of Medicinal Chemistry 2013, 56 (12) , 5208-5212. https://doi.org/10.1021/jm400439t
    37. Claudia Mugnaini, Valentina Pedani, Angelo Casu, Carla Lobina, Alberto Casti, Paola Maccioni, Alessandra Porcu, Daniela Giunta, Stefania Lamponi, Maurizio Solinas, Stefania Dragoni, Massimo Valoti, Giancarlo Colombo, Maria Paola Castelli, Gian Luigi Gessa, and Federico Corelli . Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABAB Receptor. Journal of Medicinal Chemistry 2013, 56 (9) , 3620-3635. https://doi.org/10.1021/jm400144w
    38. Euijung Jo, Barun Bhhatarai, Emanuela Repetto, Miguel Guerrero, Sean Riley, Steven J. Brown, Yasushi Kohno, Edward Roberts, Stephan C. Schürer, and Hugh Rosen . Novel Selective Allosteric and Bitopic Ligands for the S1P3 Receptor. ACS Chemical Biology 2012, 7 (12) , 1975-1983. https://doi.org/10.1021/cb300392z
    39. Gregory J. Digby, Thomas J. Utley, Atin Lamsal, Christian Sevel, Douglas J. Sheffler, Evan P. Lebois, Thomas M. Bridges, Michael R. Wood, Colleen M. Niswender, Craig W. Lindsley, and P. Jeffrey Conn . Chemical Modification of the M1 Agonist VU0364572 Reveals Molecular Switches in Pharmacology and a Bitopic Binding Mode. ACS Chemical Neuroscience 2012, 3 (12) , 1025-1036. https://doi.org/10.1021/cn300103e
    40. James Pease and Richard Horuk . Chemokine Receptor Antagonists. Journal of Medicinal Chemistry 2012, 55 (22) , 9363-9392. https://doi.org/10.1021/jm300682j
    41. James C. Tarr, Mark L. Turlington, Paul R. Reid, Thomas J. Utley, Douglas J. Sheffler, Hyekyung P. Cho, Rebecca Klar, Tristano Pancani, Michael T. Klein, Thomas M. Bridges, Ryan D. Morrison, Anna L. Blobaum, Zixui Xiang, J. Scott Daniels, Colleen M. Niswender, P. Jeffrey Conn, Michael R. Wood, and Craig W. Lindsley . Targeting Selective Activation of M1 for the Treatment of Alzheimer’s Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169. ACS Chemical Neuroscience 2012, 3 (11) , 884-895. https://doi.org/10.1021/cn300068s
    42. José-Ignacio Andrés, Jesús Alcázar, José María Cid, Meri De Angelis, Laura Iturrino, Xavier Langlois, Hilde Lavreysen, Andrés A. Trabanco, Sofie Celen, and Guy Bormans . Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging. Journal of Medicinal Chemistry 2012, 55 (20) , 8685-8699. https://doi.org/10.1021/jm300912k
    43. John T. Brogan, Sydney L. Stoops, and Craig W. Lindsley . Total Synthesis and Biological Evaluation of Phidianidines A and B Uncovers Unique Pharmacological Profiles at CNS Targets. ACS Chemical Neuroscience 2012, 3 (9) , 658-664. https://doi.org/10.1021/cn300064r
    44. Md Toufiqur Rahman, Hetti Handi Chaminda Lakmal, Javeena Hussain, Chunyang Jin. Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades. Expert Opinion on Therapeutic Patents 2024, , 1-11. https://doi.org/10.1080/13543776.2024.2338099
    45. Fentaw Girmaw. Review on allosteric modulators of dopamine receptors so far. Health Science Reports 2024, 7 (3) https://doi.org/10.1002/hsr2.1984
    46. Fadime Canbolat, Nigar Kantarci-Carsibasi, Sevim Isik, Suhair Rami Mohammed Shamshir, Münteha Girgin. Identification of the Candidate mGlu2 Allosteric Modulator THRX-195518 through In Silico Method and Evaluation of Its Neuroprotective Potential against Glutamate-Induced Neurotoxicity in SH-SY5Y Cell Line. Current Issues in Molecular Biology 2024, 46 (1) , 788-807. https://doi.org/10.3390/cimb46010051
    47. Jörn Lötsch, Benjamin Mayer, Dario Kringel. Machine learning analysis predicts a person’s sex based on mechanical but not thermal pain thresholds. Scientific Reports 2023, 13 (1) https://doi.org/10.1038/s41598-023-33337-2
    48. Weidong Zhang, Ayako Miura, Md Moin Abu Saleh, Koichiro Shimizu, Yuichiro Mita, Ryota Tanida, Satoshi Hirako, Seiji Shioda, Valery Gmyr, Julie Kerr-Conte, Francois Pattou, Chunhuan Jin, Yoshikatsu Kanai, Kazuki Sasaki, Naoto Minamino, Hideyuki Sakoda, Masamitsu Nakazato. The NERP-4–SNAT2 axis regulates pancreatic β-cell maintenance and function. Nature Communications 2023, 14 (1) https://doi.org/10.1038/s41467-023-43976-8
    49. Pooja Grewal, Navjeet Kaur. Palladium-Catalyzed C-N Coupling in the Synthesis of Benzodiazepines. Current Organic Chemistry 2023, 26 (22) , 1993-2004. https://doi.org/10.2174/1385272827666230111162038
    50. Ayame Saito, Sadia Alvi, Celine Valant, Arthur Christopoulos, Simona E. Carbone, Daniel P. Poole. Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders. British Journal of Pharmacology 2023, 50 https://doi.org/10.1111/bph.16023
    51. Jaromir Myslivecek. Multitargeting nature of muscarinic orthosteric agonists and antagonists. Frontiers in Physiology 2022, 13 https://doi.org/10.3389/fphys.2022.974160
    52. Antonios Drakopoulos, Dimitrios Moianos, Georgia‐Myrto Prifti, Grigoris Zoidis, Michael Decker. Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype. ChemMedChem 2022, 17 (14) https://doi.org/10.1002/cmdc.202200169
    53. Roberto Iorio, Giuseppe Celenza, Sabrina Petricca. Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation. Antioxidants 2022, 11 (6) , 1199. https://doi.org/10.3390/antiox11061199
    54. Justyna Żuk, Damian Bartuzi, Andrea G. Silva, Monika Pitucha, Oliwia Koszła, Tomasz M. Wróbel, Dariusz Matosiuk, Marián Castro, Agnieszka A. Kaczor. Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications. Pharmacological Reports 2022, 74 (2) , 406-424. https://doi.org/10.1007/s43440-021-00352-x
    55. Panpan Wang, Xiaonan Gao, Ke Zhang, Qinglan Pei, Xiaobo Xu, Fengmei Yan, Jianghong Dong, Chenxi Jing. Exploring the binding mechanism of positive allosteric modulators in human metabotropic glutamate receptor 2 using molecular dynamics simulations. Physical Chemistry Chemical Physics 2021, 23 (42) , 24125-24139. https://doi.org/10.1039/D1CP02157E
    56. James Neef, Daniel S. Palacios. Progress in mechanistically novel treatments for schizophrenia. RSC Medicinal Chemistry 2021, 12 (9) , 1459-1475. https://doi.org/10.1039/D1MD00096A
    57. Feifei Fang, Shulei Hu, Chunpu Li, Qian Wang, Run Wang, Xu Han, Yu Zhou, Hong Liu. Catalytic System‐Controlled Divergent Reaction Strategies for the Construction of Diversified Spiropyrazolone Skeletons from Pyrazolidinones and Diazopyrazolones. Angewandte Chemie 2021, 133 (39) , 21497-21503. https://doi.org/10.1002/ange.202105857
    58. Feifei Fang, Shulei Hu, Chunpu Li, Qian Wang, Run Wang, Xu Han, Yu Zhou, Hong Liu. Catalytic System‐Controlled Divergent Reaction Strategies for the Construction of Diversified Spiropyrazolone Skeletons from Pyrazolidinones and Diazopyrazolones. Angewandte Chemie International Edition 2021, 60 (39) , 21327-21333. https://doi.org/10.1002/anie.202105857
    59. Angela Arsova, Thor C. Møller, Shane D. Hellyer, Line Vedel, Simon R. Foster, Jakob L. Hansen, Hans Bräuner-Osborne, Karen J. Gregory. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias. Molecular Pharmacology 2021, 99 (5) , 328-341. https://doi.org/10.1124/molpharm.120.000185
    60. Shangfei Wei, Tianming Zhao, Jie Wang, Xin Zhai. Approach in Improving Potency and Selectivity of Kinase Inhibitors: Allosteric Kinase Inhibitors. Mini-Reviews in Medicinal Chemistry 2021, 21 (8) , 991-1003. https://doi.org/10.2174/1389557521666201222144355
    61. Zoltán Orgován, György G. Ferenczy, György M. Keserű. Allosteric Molecular Switches in Metabotropic Glutamate Receptors. ChemMedChem 2021, 16 (1) , 81-93. https://doi.org/10.1002/cmdc.202000444
    62. Xiaofei Zhang, Zhiwei Xiao, Katsushi Kumata, Tomoteru Yamasaki, Lee Josephson, Ming-Rong Zhang, Lu Wang, Steven H. Liang. Positron Emission Tomography (PET) Imaging of Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Based on a Negative Allosteric Modulator Radioligand. 2021, 23-37. https://doi.org/10.1007/978-1-0716-1107-4_2
    63. Benjamin E. Blass. In vitro screening systems. 2021, 185-256. https://doi.org/10.1016/B978-0-12-817214-8.00004-X
    64. Dexter C. Davis, Joseph D. Bungard, Sichen Chang, Alice L. Rodriguez, Annie L. Blobaum, Olivier Boutaud, Bruce J. Melancon, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 4: SAR reveals positive cooperativity across multiple mGlu receptor subtypes leading to subtype unselective PAMs. Bioorganic & Medicinal Chemistry Letters 2021, 32 , 127724. https://doi.org/10.1016/j.bmcl.2020.127724
    65. Vincent N. Marty, Mehdi Farokhnia, Joseph J. Munier, Yatendra Mulpuri, Lorenzo Leggio, Igor Spigelman. Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats. Frontiers in Neuroscience 2020, 14 https://doi.org/10.3389/fnins.2020.599646
    66. Álvaro Velasco‐Rubio, Jesús A. Varela, Carlos Saá. Recent Advances in Transition‐Metal‐Catalyzed Oxidative Annulations to Benzazepines and Benzodiazepines. Advanced Synthesis & Catalysis 2020, 362 (22) , 4861-4875. https://doi.org/10.1002/adsc.202000808
    67. Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, Francesco Marampon, Marco Carli, Marco Scarselli, Roberto Maggio, Mario Rossi. Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics. Pharmaceuticals 2020, 13 (11) , 388. https://doi.org/10.3390/ph13110388
    68. Linghua Zhang, Yuanshuang Xu, Xiaopeng Zhang, Xinying Zhang, Xuesen Fan. Synthesis of pyrazolone fused benzodiazepines via Rh( iii )-catalyzed [4 + 3] annulation of 1-phenylpyrazolidinones with propargyl alcohols. Organic Chemistry Frontiers 2020, 7 (16) , 2284-2290. https://doi.org/10.1039/D0QO00657B
    69. Huiqun Wang, Bethany A. Reinecke, Yan Zhang. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators. Journal of Computer-Aided Molecular Design 2020, 34 (8) , 879-895. https://doi.org/10.1007/s10822-020-00309-x
    70. Kirsten Antonio-Tolentino, Corey R. Hopkins. Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia – a review. Expert Opinion on Investigational Drugs 2020, 29 (6) , 603-610. https://doi.org/10.1080/13543784.2020.1764938
    71. Ajay Kumar, Ravi Kumar Chaudhary, Rachita Singh, Satya P. Singh, Shao-Yu Wang, Zheng-Yu Hoe, Cheng-Tang Pan, Yow-Ling Shiue, Dong-Qing Wei, Aman Chandra Kaushik, Xiaofeng Dai. Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases. Frontiers in Neuroscience 2020, 14 https://doi.org/10.3389/fnins.2020.00305
    72. Víctor Fernández-Dueñas, Mingcheng Qian, Josep Argerich, Carolina Amaral, Martijn D.P. Risseeuw, Serge Van Calenbergh, Francisco Ciruela. Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators. Molecules 2020, 25 (7) , 1532. https://doi.org/10.3390/molecules25071532
    73. María L. López-Rodríguez, Bellinda Benhamú, Henar Vázquez-Villa. Allosteric modulators targeting GPCRs. 2020, 195-241. https://doi.org/10.1016/B978-0-12-816228-6.00011-8
    74. Eric A. Wold, Christopher T. Wild, Kathryn A. Cunningham, Jia Zhou. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. Current Topics in Medicinal Chemistry 2019, 19 (16) , 1381-1398. https://doi.org/10.2174/1568026619666190709101449
    75. Youwen Xu, Zizhong Li. Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development. Medicinal Research Reviews 2019, 39 (5) , 1892-1922. https://doi.org/10.1002/med.21566
    76. Mohammed Nooraldeen Mahmod Al-Qattan, Mohd Nizam Mordi. Molecular Basis of Modulating Adenosine Receptors Activities. Current Pharmaceutical Design 2019, 25 (7) , 817-831. https://doi.org/10.2174/1381612825666190304122624
    77. Maan T. Khayat, Ahmad Hanif, Werner J. Geldenhuys, Mohammed A. Nayeem. Adenosine Receptors and Drug Discovery in the Cardiovascular System. 2019, 65-82. https://doi.org/10.2174/9781681083995118040004
    78. Pavan V. Payghan, Indrani Bera, Dhananjay Bhattacharyya, Nanda Ghoshal. Computational Studies for Structure-Based Drug Designing Against Transmembrane Receptors: pLGICs and Class A GPCRs. Frontiers in Physics 2018, 6 https://doi.org/10.3389/fphy.2018.00052
    79. Sara Patruno, Jose Garrido-Mesa, Mario Romano, Mauro Perretti, Trinidad Montero-Melendez. Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs. Frontiers in Pharmacology 2018, 9 https://doi.org/10.3389/fphar.2018.00919
    80. Jeanette L. Bertron, Hyekyung P. Cho, Pedro M. Garcia-Barrantes, Joseph D. Panarese, James M. Salovich, Kellie D. Nance, Darren W. Engers, Jerri M. Rook, Anna L. Blobaum, Colleen M. Niswender, Shaun R. Stauffer, P. Jeffrey Conn, Craig W. Lindsley. The discovery of VU0486846: steep SAR from a series of M1 PAMs based on a novel benzomorpholine core. Bioorganic & Medicinal Chemistry Letters 2018, 28 (12) , 2175-2179. https://doi.org/10.1016/j.bmcl.2018.05.009
    81. Christian C. Felder, Paul J. Goldsmith, Kimberley Jackson, Helen E. Sanger, David A. Evans, Adrian J. Mogg, Lisa M. Broad. Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases. Neuropharmacology 2018, 136 , 449-458. https://doi.org/10.1016/j.neuropharm.2018.01.028
    82. Manjoorahmed Asamdi, Mohammedumar M. Shaikh, Prakashsingh M. Chauhan, Kishor H. Chikhalia. Palladium-catalyzed [5+2] oxidative annulation of N-Arylhydrazones with alkynes through C H activation to synthesize Benzo[d][1,2]diazepines. Tetrahedron 2018, 74 (27) , 3719-3727. https://doi.org/10.1016/j.tet.2018.05.051
    83. Kathryn E Livingston, John R Traynor. Allostery at opioid receptors: modulation with small molecule ligands. British Journal of Pharmacology 2018, 175 (14) , 2846-2856. https://doi.org/10.1111/bph.13823
    84. Hiroaki Kume, Osamu Nishiyama, Takaaki Isoya, Yuji Higashimoto, Yuji Tohda, Yukihiro Noda. Involvement of Allosteric Effect and KCa Channels in Crosstalk between β2-Adrenergic and Muscarinic M2 Receptors in Airway Smooth Muscle. International Journal of Molecular Sciences 2018, 19 (7) , 1999. https://doi.org/10.3390/ijms19071999
    85. Shane D. Hellyer, Sabine Albold, Taide Wang, Amy N. Y. Chen, Lauren T. May, Katie Leach, Karen J. Gregory. “Selective” Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu 5 Allosteric Ligands. Molecular Pharmacology 2018, 93 (5) , 504-514. https://doi.org/10.1124/mol.117.111518
    86. Kathy Sengmany, Karen J. Gregory. Drugs to Tune Up Glutamatergic Systems: Modulators of Glutamate Metabotropic Receptors. 2018, 227-261. https://doi.org/10.1007/978-1-4939-7228-9_8
    87. Yuemin Bian, Zhiwei Feng, Peng Yang, Xiang-Qun Xie. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5. The AAPS Journal 2017, 19 (4) , 1235-1248. https://doi.org/10.1208/s12248-017-0093-5
    88. Sunil Goodwani, Hannah Saternos, Fawaz Alasmari, Youssef Sari. Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. Neuroscience & Biobehavioral Reviews 2017, 77 , 14-31. https://doi.org/10.1016/j.neubiorev.2017.02.024
    89. Trinidad Montero-Melendez, Rachel A. E. Forfar, Jennifer M. Cook, Jeffrey C. Jerman, Debra L. Taylor, Mauro Perretti. Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3. Cellular and Molecular Life Sciences 2017, 74 (7) , 1335-1345. https://doi.org/10.1007/s00018-016-2419-3
    90. Kevin M. McGowan, Kellie D. Nance, Hykeyung P. Cho, Thomas M. Bridges, P. Jeffrey Conn, Carrie K. Jones, Craig W. Lindsley. Continued optimization of the M 5 NAM ML375: Discovery of VU6008667, an M 5 NAM with high CNS penetration and a desired short half-life in rat for addiction studies. Bioorganic & Medicinal Chemistry Letters 2017, 27 (6) , 1356-1359. https://doi.org/10.1016/j.bmcl.2017.02.020
    91. Kathy Sengmany, Junaid Singh, Gregory D. Stewart, P. Jeffrey Conn, Arthur Christopoulos, Karen J. Gregory. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery. Neuropharmacology 2017, 115 , 60-72. https://doi.org/10.1016/j.neuropharm.2016.07.001
    92. Raquel Pérez-Sen, Rosa Gómez-Villafuertes, Felipe Ortega, Javier Gualix, Esmerilda G. Delicado, María Teresa Miras-Portugal. An Update on P2Y13 Receptor Signalling and Function. 2017, 139-168. https://doi.org/10.1007/5584_2017_91
    93. S. Lu, J. Zhang. Allosteric Modulators. 2017, 276-296. https://doi.org/10.1016/B978-0-12-409547-2.12324-8
    94. Abhijit R. Kulkarni, Sumanta Garai, David R. Janero, Ganesh A. Thakur. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications. 2017, 281-315. https://doi.org/10.1016/bs.mie.2017.06.018
    95. Verena Peters, Claus P. Schmitt, Tim Weigand, Kristina Klingbeil, Christian Thiel, Antje van den Berg, Vittorio Calabrese, Peter Nawroth, Thomas Fleming, Elisabete Forsberg, Andreas H. Wagner, Markus Hecker, Giulio Vistoli. Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift. Journal of Enzyme Inhibition and Medicinal Chemistry 2017, 32 (1) , 1102-1110. https://doi.org/10.1080/14756366.2017.1355793
    96. Liting Deng, Lindsay Ng, Tatsuya Ozawa, Nephi Stella. Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture. Journal of Pharmacology and Experimental Therapeutics 2017, 360 (1) , 215-224. https://doi.org/10.1124/jpet.116.236968
    97. Dario Doller, Xinyan Huang. Modulation of Biological Targets Using Allosteric Ligands: Food for Thought. 2016, 1-23. https://doi.org/10.1039/9781782629276-00001
    98. Mélanie Frauli, Christel Franchet, Ismet Dorange, Arturo Mancini, Billy Breton, Stephan Schann. Molecular Biology Techniques Applied to GPCR Allosteric and Biased Ligands. 2016, 65-96. https://doi.org/10.1039/9781782629276-00065
    99. Bruce J. Melancon, Corey R. Hopkins. Muscarinic Receptors Allosteric Modulation. 2016, 175-193. https://doi.org/10.1039/9781782629276-00175
    100. K Sengmany, K J Gregory. Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias. British Journal of Pharmacology 2016, 173 (20) , 3001-3017. https://doi.org/10.1111/bph.13281
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect